With decades of experience in academics, industry, and consulting in a wide range of therapeutic areas, Endpoint LLC can provide authoritative, comprehensive advice to multinationals, biotech start-ups, charitable medical foundations, governmental bodies, and biotech investors.
Strategic Drug & Device Development
Details
- evaluate the medical and commercial potential of products in preclinical or early clinical development
- formulate comprehensive clinical development plans to the highest medical, scientific, and ethical standards
- position products for optimal marketing through a carefully integrated Phase I through IV clinical trials program
- optimize go/no-go decision points during product development
- help emerging companies articulate a comprehensive approach to product development customized to their compound or device, planned indication, and specific corporate needs
- interact with regulatory agencies to gain endorsement of the clinical trial program and planned regulatory submission
- assist with strategic planning of FDA advisory committee presentations